Description |
Product Type |
Product Size |
Capsules |
14'S |
Product Company |
Searle Iv SOLN |
Omeprazole 20mg |
Product Type |
Product Size |
Capsules |
21'S |
Product Company |
Getz Pharma |
Omeprazole 40mg
|
Product Type |
Product Size |
Capsules |
14'S |
Product Company |
Getz Pharma |
Omeprazole 20mg
|
Product Type |
Product Size |
Tablet |
600'S |
Product Company |
Pfizer |
Mefenamic acid 250mg |
Product Type |
Product Size |
Capsules |
14'S |
Product Company |
Searle Iv SOLN |
Omeprazole 40mg |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Himmel Pharma
|
Carboplatin 150mg/15ml |
Content | Omeprazole is used to treat frequent heartburn (heartburn that occurs at least 2 or more days a week) in adults. Omeprazole is in a class of medications called proton-pump inhibitors. | Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). It works by decreasing the amount of acid your stomach
| omeprazole is used to treat frequent heartburn (heartburn that occurs at least 2 or more days a week) in adults. Omeprazole is in a class of medications called proton-pump inhibitors.
| Mefenamic acid is used for the short-term relief of mild to moderate pain from various conditions such as headache, dental pain, menstrual cramps, and muscle aches.Mefenamic acid is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. | omeprazole is used to treat frequent heartburn (heartburn that occurs at least 2 or more days a week) in adults. Omeprazole is in a class of medications called proton-pump inhibitors. | Carboplatin is an alkylating agent used to treat advanced ovarian cancer.Carboplatin is indicated in combination with an established combination of chemotherapeutic agents for the initial treatment of advanced ovarian carcinoma. Carboplatin is also indicated for the palliative treatment of ovarian carcinoma, recurrent after prior chemotherapy.
|
Reviews
There are no reviews yet.